KangaBio, located in the Zhangjiang Biomedicine Valley of Shanghai, was founded in 2021 by Dr. Weidong Jiang. KangaBio is a biotech company focused on providing innovative medicine to address unmet medical needs. We are working on developing prodrugs of immune-stimulating agents and other multi-specific biologics to avoid toxicities for previously validated targets and to increase drug efficacy.

Dr. Jiang previously co-founded Shanghai Henlius Biotech in 2009, a public company listed on Hong Kong stock exchange with five successfully launched biologics in the Chinese market as well as one in the European market. We are growing rapidly and recruiting global talent, centering our core values on speed, quality, globalization, and accountability.